...
机译:HBOA通过抑制TGF-β1/ Smad,NF-Kappa B和ERK信号通路来改善CCL4-Incuct肝纤维化
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Guangxi Med Univ Dept Pharmacol Nanning 530021 Peoples R China;
Hepatic fibrosis; 4-Hydroxy-2(3H)-benzoxazolone (HBOA); TGF-beta 1/Smads pathway; NE-kappa B pathway; ERK pathway; Apoptosis;
机译:HBOA通过抑制TGF-β1/ Smad,NF-Kappa B和ERK信号通路来改善CCL4-Incuct肝纤维化
机译:通过抑制TGF-Beta 1 / Smads信号通路改善了大鼠肾纤维化的肾纤维化
机译:抑制eIF3a可以通过抑制TGF-beta 1 / Smad3信号通路改善心脏纤维化
机译:TGF-β和CTGF介导的信号转导途径和纤维化
机译:人上皮MCF10A细胞谱系中TGF-beta / Smad和PI3K / Akt通路之间的串扰和信号抑制剂的含义。
机译:ERK / MAPK和TGF-β/ Smad信号通路均在血糖波动加速的糖尿病小鼠肾脏纤维化中发挥作用
机译:中药CGA配方通过抑制MMP2 / 9,TIMP1 / 2和TGF-β/ SMAD信号通路改善大鼠DMN诱导的肝纤维化